Joined in 2023 
82 
63 About this deal
Relatively large quantities of therapeutic ingredients may be supplied into the skin with the “poke and flow” approach, which, by using hollow MNs, could potentially overcome the dose limitation associated with solid MNs [ 49]. With hollow MNs, it is technically possible to control the flow and dosing by diffusion or pressure or electronically (e.g., using a pump), and to integrate them into lab-on-chip devices. Similarly, bio-macromolecules, including proteins, vaccines, mRNA, and diagnostic agents, can be delivered via hollow MNs [ 50, 51]. These MNs can also be used for the isolation and identification of biomarkers including glucose [ 52], and ECG measurements [ 53]. Nonetheless, the construction of hollow MNs is relatively complicated and suffers from clogging, drug leakage, structural fragility, and the requirement of a larger tip diameter, which leads to poor insertion. Jiang, B. et al. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum. Vaccin. 4, 143–147 (2008). Microneedle patches can also be used to deliver targeted treatments, such as hydrating hyaluronic acid and anti-ageing peptides, deeper into the skin rendering them even more effective. How Safe Are Microneedle Patches? We can also see there being a role for these patches in the health and wellness fields,” she said. “I can picture the day people have microneedles under their smartwatches to detect fluctuations in the stress hormone, cortisol.”
PATCH PRO MICRO NEEDLE PATCH Trouble Dr. 18pcs, microneedle PATCH PRO MICRO NEEDLE PATCH Trouble Dr. 18pcs, microneedle
Editor’s note: This article has been updated to clarify that this research was developed to help avoid preventable deaths in parts of the world where paper or digital systems for storing patients’ vaccination records aren’t available. Many vaccines require multiple doses spaced out at certain intervals; without accurate records, people may not receive all of the necessary doses. The method is still in an experimental stage and is not being used for any current vaccinations, including Covid-19 vaccines. Prausnitz’s team designed the dime-sized patch of microneedles used in the study. The patch consists of 100 solid, water-soluble needles that contain flu vaccine. The needles are just long enough to penetrate the skin. They dissolve within the skin in minutes. Unlike the liquid flu shot, the patch doesn’t require refrigeration.First-generation IRV-dMNP to deliver 5 µg of IRV were fabricated and stored at 5, 25 or 40 °C for up to 24 months, whereas IPV-dMNP to deliver 20, 4, and 16 DU (half the commercial dose) of IPV types 1, 2, and 3, respectively were fabricated and stored at 5 or 25 °C for up to 12 weeks. IPV-dMNP stability at 40 °C was not evaluated. The dMNP were tested for IRV or IPV potency by ELISA using a rotavirus VP7-specific monoclonal antibody or monoclonal antibodies to poliovirus types 1, 2, and 3 25, 40. All dMNP were monitored for appearance (e.g., specified number of MNs, free of debris, appropriate shape, and color) throughout the stability studies. Animal studies Jiang, B. et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 17, 1005–1013 (1999).
Microneedle patch for flu vaccine | National Institutes of
The microneedles used in this study are made from a mixture of dissolvable sugar and a polymer called PVA, as well as the quantum-dot dye and the vaccine. When the patch is applied to the skin, the microneedles, which are 1.5 millimeters long, partially dissolve, releasing their payload within about two minutes. An affordable microneedle skin patch that delivers a controlled dosage of medicine directly into the body, eliminating the need for injections or oral medication, has been developed by a team led by scientists at the University of Bath.Qiu, Y. et al. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Deliv. 23, 2391–2398 (2016). Edens, C., Collins, M. L., Ayers, J., Rota, P. A. & Prausnitz, M. R. Measles vaccination using a microneedle patch. Vaccine 31, 3403–3409 (2013). With the rapid development of nanotechnology, microneedle patches have been improved by switching from undissolving to dissolving microneedles, and their safety has also improved dramatically. As a drug delivery tool, microneedle patches can deliver bioactive molecular of different physical size. Additionally, microneedle patches can be coated or encapsulate with DNA vaccine, subunit antigen, inactivated or live virus vaccine. Combining clinical results with the results of patient interview, microneedle patches are found to be feasible and are predicated to soon be acceptable for the medical service. The researchers now plan to survey health care workers in developing nations in Africa to get input on the best way to implement this type of vaccination record keeping. They are also working on expanding the amount of data that can be encoded in a single pattern, allowing them to include information such as the date of vaccine administration and the lot number of the vaccine batch. Armah, G. et al. A randomized, controlled trial of the impact of alternative dosing schedules on the immune response to human rotavirus vaccine in rural Ghanaian infants. J. Infect. Dis. 213, 1678–1685 (2016).
Microneedle drug delivery - Wikipedia
Microneedle patches full of active ingredients designed to help manage spots and breakouts, reducing the time it takes for these pesky blemishes to disappear. Also, sometimes the use of needles can introduce pathogens, such as bacteria, that may cause infections, especially in people with low immunity.”Jiang, B., Wang, Y. & Glass, R. I. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies. Hum. Vaccin. Immunother. 9, 1634–1637 (2013). In experiments carried out at Bath, upon swelling, the patches delivered doses of antibiotics that elicited a strong response against two bacteria known to cause serious infections – Escherichia coli (E. coli) and Staphylococcus aureus. Preclinical studies with the SARS-CoV-2 HexaPro modified spike protein 24 have shown that the protein can be formulated, dried, and stabilized on the HD-MAP. 21 In a mouse model, delivery of HexaPro on the HD-MAP was superior to intradermal (ID) delivery with N&S, inducing high titers of antibodies capable of neutralizing a range of SARS-CoV-2 VoCs, including Alpha and Beta. 25 In a transgenic mouse model, vaccination with a single dose of HexaPro plus the adjuvant QS21 on HD-MAPs elicited 100% protection from a lethal SARS-CoV-2 virus challenge. Without the adjuvant, two doses of HexaPro were sufficient for protection. 25 Tests using human cadaver skin showed that the quantum-dot patterns could be detected by smartphone cameras after up to five years of simulated sun exposure. Nair, N. et al. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci. Transl. Med. 9, eaam543 (2017).
Great Deal 
New Comment